Please check your internet connection and try again.
## Atta-drugs (Folic Acid)
### Overview
Folic acid, also known as vitamin B9, is essential for DNA synthesis and repair, red blood cell formation, and fetal neural tube development.
### Primary Indications
* Treatment and prevention of folate deficiency anemia.
* Prevention of neural tube defects in pregnant women.
* Adjunct in certain chemotherapy regimens to reduce toxicity.
### Adult Dosing
* **Folate Deficiency Anemia:** 1 mg to 5 mg daily. Higher doses may be needed in malabsorption states.
* **Neural Tube Defect Prevention:** 0.4 mg to 1 mg daily, starting at least 1 month prior to conception and continuing through the first trimester of pregnancy. For women with a history of neural tube defects, 4 mg daily is recommended.
* **Chemotherapy Adjunct (e.g., Methotrexate):** Dosing varies significantly based on chemotherapy regimen and local protocol. Typically ranges from 5 mg to 15 mg daily or weekly, often initiated 24 hours after methotrexate administration.
### Pediatric Dosing
* **Folate Deficiency Anemia:** 0.1 mg to 1 mg daily, depending on age and severity.
* Infants: 0.05 mg to 0.1 mg daily.
* Children 1-10 years: 0.1 mg to 0.3 mg daily.
* Children >10 years: 0.2 mg to 0.5 mg daily.
* **Neural Tube Defect Prevention:** 0.4 mg daily for women of childbearing potential. For women with a history of neural tube defects, 4 mg daily is recommended.
### Dose Adjustments
* No specific dose adjustments are typically required for renal or hepatic impairment, as folic acid is water-soluble and readily metabolized.
### Contraindications
* Uncorrected vitamin B12 deficiency (folic acid may mask hematologic signs of B12 deficiency, allowing neurological damage to progress).
### Adverse Effects
Folic acid is generally well-tolerated.
* **Common:** Gastrointestinal upset (nausea, bloating), allergic reactions (rare).
* **Rare:** Bronchospasm.
### Key Drug Interactions
* **Anticonvulsants (e.g., Phenytoin, Phenobarbital, Primidone):** Folic acid may decrease serum concentrations of these drugs, potentially leading to loss of seizure control. Monitor anticonvulsant levels and seizure frequency.
* **Sulfasalazine:** May interfere with folate absorption and metabolism.
* **Methotrexate:** Folic acid is used as a rescue agent to mitigate methotrexate toxicity. The timing and dose are critical and dictated by specific protocols.
### Monitoring
* **For Anemia:** Monitor hemoglobin, hematocrit, and reticulocyte count.
* **For Patients on Anticonvulsants:** Monitor anticonvulsant drug levels and seizure activity.
* **For Patients on Chemotherapy:** Monitor for signs of toxicity as per specific protocol.
### Clinical Pearls
* Folic acid can mask the hematologic manifestations of vitamin B12 deficiency. It is crucial to rule out or treat concurrent B12 deficiency before initiating folic acid therapy, especially in the elderly or those with risk factors for B12 deficiency.
* The dose of folic acid required for neural tube defect prevention differs significantly for women with a history of affected pregnancies (4 mg daily) compared to the general population (0.4 mg daily).
* Ensure patients understand the critical timing and dosage for folic acid "rescue" when taking certain chemotherapies like methotrexate.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and local institutional guidelines for definitive patient care decisions.
